These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 10573494)
1. Effect of cholesterol lowering treatment on positive exercise tests in patients with hypercholesterolaemia and normal coronary angiograms. Mansur AP; Serrano CV; Nicolau JC; César LA; Ramires JA Heart; 1999 Dec; 82(6):689-93. PubMed ID: 10573494 [TBL] [Abstract][Full Text] [Related]
2. Simvastatin compared to fluvastatin in the reduction of serum lipids and apolipoproteins in patients with ischaemic heart disease and moderate hypercholesterolaemia. Sigurdsson G; Haraldsdottir SO; Melberg TH; Tikkanen MJ; Miettinen TE; Kristianson KJ Acta Cardiol; 1998; 53(1):7-14. PubMed ID: 9638964 [TBL] [Abstract][Full Text] [Related]
3. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. Stefanick ML; Mackey S; Sheehan M; Ellsworth N; Haskell WL; Wood PD N Engl J Med; 1998 Jul; 339(1):12-20. PubMed ID: 9647874 [TBL] [Abstract][Full Text] [Related]
4. [Improved coronary vasodilator capacity by drug lipid lowering therapy in patients in the early stage of coronary atherosclerosis with reduced coronary reserves and moderate LDL hypercholesteremia]. Baller D; Gleichmann U; Notohamiprodjo G; Weise R; Holzinger J; Montanus H; Betker S; Lehmann J Z Kardiol; 1998; 87 Suppl 2():136-44. PubMed ID: 9827472 [TBL] [Abstract][Full Text] [Related]
5. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial. Stender S; Schuster H; Barter P; Watkins C; Kallend D; Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130 [TBL] [Abstract][Full Text] [Related]
6. Cholesterol lowering with statins reduces exercise-induced myocardial ischemia in hypercholesterolemic patients with coronary artery disease. Ramires JA; Sposito AC; Mansur AP; Coelho OR; Maranhão M; Cesar LA Am J Cardiol; 2001 Nov; 88(10):1134-8. PubMed ID: 11703958 [TBL] [Abstract][Full Text] [Related]
7. Comparison of a dietary portfolio diet of cholesterol-lowering foods and a statin on LDL particle size phenotype in hypercholesterolaemic participants. Gigleux I; Jenkins DJ; Kendall CW; Marchie A; Faulkner DA; Wong JM; de Souza R; Emam A; Parker TL; Trautwein EA; Lapsley KG; Connelly PW; Lamarche B Br J Nutr; 2007 Dec; 98(6):1229-36. PubMed ID: 17663803 [TBL] [Abstract][Full Text] [Related]
8. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia]. Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901 [TBL] [Abstract][Full Text] [Related]
9. Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS). Aengevaeren WR; Kroon AA; Stalenhoef AF; Uijen GJ; van der Werf T J Am Coll Cardiol; 1996 Dec; 28(7):1696-704. PubMed ID: 8962554 [TBL] [Abstract][Full Text] [Related]
10. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. Cziraky MJ; Watson KE; Talbert RL J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279 [TBL] [Abstract][Full Text] [Related]
11. Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia. Malini PL; Ambrosioni E; De Divitiis O; Di Somma S; Rosiello G; Trimarco B Clin Ther; 1991; 13(4):500-10. PubMed ID: 1934003 [TBL] [Abstract][Full Text] [Related]
12. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study. Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916 [TBL] [Abstract][Full Text] [Related]
14. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men. Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E; J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343 [TBL] [Abstract][Full Text] [Related]
15. Low plasma lipid levels and increased cholesterol synthesis after partial ileal bypass plus lovastatin in hypercholesterolemic rabbits. Tijerina O; Dombrovskis S; Esper E; Matts JP; Campos CT; Buchwald H Surgery; 1988 Oct; 104(4):796-805. PubMed ID: 3175875 [TBL] [Abstract][Full Text] [Related]
16. A one-year multicentre study of simvastatin in the treatment of hypercholesterolaemia. UK and Eire Simvastatin Study Group. Br J Clin Pract; 1994; 48(5):231-5. PubMed ID: 7917813 [TBL] [Abstract][Full Text] [Related]
17. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation. Lintott CJ; Scott RS; Sharpe DN; Nye ER; Charleson H; French JK; White HD; Reuben S; Maling TJ; Lewis GR Med J Aust; 1991 Oct; 155(7):433-6. PubMed ID: 1921811 [TBL] [Abstract][Full Text] [Related]
18. Long-term safety of statin-fibrate combination treatment in the management of hypercholesterolaemia in patients with coronary artery disease. Feher MD; Foxton J; Banks D; Lant AF; Wray R Br Heart J; 1995 Jul; 74(1):14-7. PubMed ID: 7662446 [TBL] [Abstract][Full Text] [Related]
19. Simvastatin in non-insulin-dependent diabetic patients with hypercholesterolaemia. Steyn K; Weich HF; Bonnici F; Kotze TJ; Stander I; Vermaak WJ; Lourens W; van Lathem J; Omar MA; Fourie J S Afr Med J; 1992 Dec; 82(6):402-6. PubMed ID: 1465688 [TBL] [Abstract][Full Text] [Related]
20. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS). Lancet; 1994 Sep; 344(8923):633-8. PubMed ID: 7864934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]